Literature DB >> 17923478

DNA accelerates the inhibition of human cathepsin V by serpins.

Poh Chee Ong1, Sheena McGowan, Mary C Pearce, James A Irving, Wan-Ting Kan, Sergei A Grigoryev, Boris Turk, Gary A Silverman, Klaudia Brix, Stephen P Bottomley, James C Whisstock, Robert N Pike.   

Abstract

A balance between proteolytic activity and protease inhibition is crucial to the appropriate function of many biological processes. There is mounting evidence for the presence of both papain-like cysteine proteases and serpins with a corresponding inhibitory activity in the nucleus. Well characterized examples of cofactors fine tuning serpin activity in the extracellular milieu are known, but such modulation has not been studied for protease-serpin interactions within the cell. Accordingly, we present an investigation into the effect of a DNA-rich environment on the interaction between model serpins (MENT and SCCA-1), cysteine proteases (human cathepsin V and human cathepsin L), and cystatin A. DNA was indeed found to accelerate the rate at which MENT inhibited cathepsin V, a human orthologue of mammalian cathepsin L, up to 50-fold, but unexpectedly this effect was primarily effected via the protease and secondarily by the recruitment of the DNA as a "template" onto which cathepsin V and MENT are bound. Notably, the protease-mediated effect was found to correspond both with an altered substrate turnover and a conformational change within the protease. Consistent with this, cystatin inhibition, which relies on occlusion of the active site rather than the substrate-like behavior of serpins, was unaltered by DNA. This represents the first example of modulation of serpin inhibition of cysteine proteases by a co-factor and reveals a mechanism for differential regulation of cathepsin proteolytic activity in a DNA-rich environment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923478     DOI: 10.1074/jbc.M706991200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Nuclear cysteine cathepsin variants in thyroid carcinoma cells.

Authors:  Sofia Tedelind; Kseniia Poliakova; Amanda Valeta; Ruth Hunegnaw; Eyoel Lemma Yemanaberhan; Nils-Erik Heldin; Junichi Kurebayashi; Ekkehard Weber; Nataša Kopitar-Jerala; Boris Turk; Matthew Bogyo; Klaudia Brix
Journal:  Biol Chem       Date:  2010-08       Impact factor: 3.915

Review 2.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

3.  Effects of extracellular DNA on plasminogen activation and fibrinolysis.

Authors:  Andrey A Komissarov; Galina Florova; Steven Idell
Journal:  J Biol Chem       Date:  2011-10-05       Impact factor: 5.157

4.  A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting.

Authors:  Adriana M G Ibelli; Tae K Kim; Creston C Hill; Lauren A Lewis; Mariam Bakshi; Stephanie Miller; Lindsay Porter; Albert Mulenga
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

5.  Heparin enhances serpin inhibition of the cysteine protease cathepsin L.

Authors:  Wayne J Higgins; Denise M Fox; Piotr S Kowalski; Jens E Nielsen; D Margaret Worrall
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

6.  Stefin B interacts with histones and cathepsin L in the nucleus.

Authors:  Slavko Ceru; Spela Konjar; Katarina Maher; Urska Repnik; Igor Krizaj; Mojca Bencina; Miha Renko; Alain Nepveu; Eva Zerovnik; Boris Turk; Natasa Kopitar-Jerala
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

Review 7.  Exosite determinants of serpin specificity.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

8.  Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.

Authors:  Gemma Ferrer-Mayorga; Silvia Alvarez-Díaz; Noelia Valle; Javier De Las Rivas; Marta Mendes; Rodrigo Barderas; Francesc Canals; Olga Tapia; J Ignacio Casal; Miguel Lafarga; Alberto Muñoz
Journal:  J Biol Chem       Date:  2015-09-13       Impact factor: 5.157

9.  Conformational change in the chromatin remodelling protein MENT.

Authors:  Poh Chee Ong; Sarah J Golding; Mary C Pearce; James A Irving; Sergei A Grigoryev; Debbie Pike; Christopher G Langendorf; Tanya A Bashtannyk-Puhalovich; Stephen P Bottomley; James C Whisstock; Robert N Pike; Sheena McGowan
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

10.  Nuclear legumain activity in colorectal cancer.

Authors:  Mads H Haugen; Harald T Johansen; Solveig J Pettersen; Rigmor Solberg; Klaudia Brix; Kjersti Flatmark; Gunhild M Maelandsmo
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.